(Allergan plc)

	AGN latest price $221.5364 (0.01%) ($220.4199 - $222.9733) on Mon. Jun. 5, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.86% (three month average)
RSI	48
Latest Price	$221.5364(0.01%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.5% a day on average for past five trading days.
Weekly Trend	AGN advances 1% a week on average for past two weeks.
Market Behavior	Normal for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(45%)    SPY(44%)    ARKG(43%)
Factors Impacting AGN price	AGN will decline at least -0.43% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-15%)    SHY(-3%)    GDXJ(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.43% (StdDev 0.86%)
Hourly BBV	0 ()
Intraday Trend	-0.5%

5 Day Moving Average	$219.34(1%)
10 Day Moving Average	$217.77(1.73%)
20 Day Moving Average	$219.26(1.04%)
To recent high	-6.8%
To recent low	4.3%
Market Cap	$73.041b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed